Pseudohypoaldosteronism.
Riepe FG.
Endocr Dev. 2013;24:86-95. doi: 10.1159/000342508. Epub 2013 Feb 1.
[Pseudohypoaldosteronism].
Arai K, Naruse K, Tanabe A, Naruse M, Demura H.
Nihon Rinsho. 1996 Mar;54(3):812-8.
[Pseudohypoaldosteronism type I].
Kaneko K.
Nihon Jinzo Gakkai Shi. 2011;53(2):150-4.
Classification of pseudohypoaldosteronism type II as type IV renal tubular acidosis: results of a literature review.
Adachi M, Motegi S, Nagahara K, Ochi A, Toyoda J, Mizuno K.
Endocr J. 2023 Jul 28;70(7):723-729. doi: 10.1507/endocrj.EJ22-0607. Epub 2023 May 19.
Transient pseudohypoaldosteronism: a potentially severe condition affecting infants with urinary tract malformation.
Delforge X, Kongolo G, Cauliez A, Braun K, Haraux E, Buisson P.
J Pediatr Urol. 2019 May;15(3):265.e1-265.e7. doi: 10.1016/j.jpurol.2019.03.002. Epub 2019 Mar 9.
Pseudohypoaldosteronism type 1b in fraternal twins of a Chinese family: report of two cases and literature review.
Gao Z, Sun J, Cai C, Gong X, Ma L.
Arch Endocrinol Metab. 2023 May 12;67(4):e000620. doi: 10.20945/2359-3997000000620.
[Neonatal systemic pseudohypoaldosteronism type I].
Cao XC, Chen YY, Zhang K, Zhang XJ, Yang L, Li ZH.
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jul 15;25(7):774-778. doi: 10.7499/j.issn.1008-8830.2305011.
Pseudohypoaldosteronism: mutation found, problem solved?
Kuhnle U.
Mol Cell Endocrinol. 1997 Oct 20;133(2):77-80. doi: 10.1016/s0303-7207(97)00149-4.
Pseudohypoaldosteronism type II: history, arguments, answers, and still some questions.
Healy JK.
Hypertension. 2014 Apr;63(4):648-54. doi: 10.1161/HYPERTENSIONAHA.113.02187. Epub 2014 Jan 6.
Pseudohypoaldosteronism: options for consideration.
Komesaroff PA.
Steroids. 1995 Jan;60(1):168-72. doi: 10.1016/0039-128x(94)00015-5.
